Skip to main content
PLOS One logoLink to PLOS One
. 2022 Jul 1;17(7):e0269520. doi: 10.1371/journal.pone.0269520

The impact of insurance institutional investors on corporate value from selection and creation perspective

Xing Rong 1, Tingting Zhang 1, Kai Liu 2,3,4,*
Editor: J E Trinidad Segovia5
PMCID: PMC9249200  PMID: 35776721

Abstract

The majority of insurance investment funds are derived from policy liability debt funds. It differs from other institutional investors in a number of ways, including investment size, horizon, duration, risk, and so on. However, only a small portion of the extant literature focuses on in-depth and extensive analysis of Insurance Institutional Investors’ holdings (IIIs). This study analyses the impact of shareholding by insurance institutions on the value of Shanghai and Shenzhen A-share listed companies in China’s capital market. The paper offers three major contributions. First, we discovered that long-term equity-holding IIIs have both value selection and value creation functions. Second, the value creation function becomes more significant among long-term stock-holding IIIs with an increase in the period during which they retain the company’s shares; Third, fast-in and fast-out (FIFO) IIIs have a value-inhibiting effect on the held company and serve a value selection role, rather than a value creation function. This study provides more insight on the lack of academic interest in insurance institutions and serves as a foundation and reference for the design of regulatory policies for insurance institutions’ involvement in stock markets. It also gives empirical evidence for corporations to accurately analyze shareholding by insurance institutions. Furthermore, since this study concentrates on China’s capital market, it can serve as a benchmark for other nations, particularly, those designated as developing market economies.

Introduction

Insurance institutions maintain a position that cannot be overlooked as key institutional investors in capital markets across the globe. According to the data of China insurance Yearbook, the insurance industry accounted for 17.8% of the global financial industry’s total assets in the fourth quarter of 2019. US insurance institutions had $6.5 trillion in financial assets and held more than 25% of US corporate bonds in 2017 [1]. Insurance funds, unlike other institutional investors, are mostly debt funds fueled by policy obligations, rather than self-owned investment funds [2]. Thus, the size, horizon, duration, and risk of insurance funds are determined by the characteristics of the funds held, which must be matched with the insurance holders’ liabilities [3]. Their impact on investee companies is likely to differ from that of other institutional investors due to these unique characteristics. The controversy over Insurance Institutional Investors’ holdings (IIIs) controlling the Chinese real estate company, Vanke Group over the nearly 3-year long period from 2015 to 2017, led to insurance funds being dubbed "barbaric funds" in China, and sparked interest and discussion about IIIs. This negative impression regarding IIIs have not yet been overcome. Regrettably, most extant academic circles conduct research on institutional investors as a whole, with few focusing on the specific impact of IIIs’ shareholding on company value.

Institutional investors are a significant source of capital with significant financial strength and investment potential [4], and a large body of research examines whether institutional investor stockholding can increase the value of the company owned. The available literature on institutional investors’ role can be divided into three groups. (1) Institutional investors, according to one viewpoint, will actively participate in corporate governance, and thereby effectively boosting company performance and value [58]. According to this view, institutional investors can effectively supervise the company’s investment operations [9], improve the quality of earnings [1013], or cut agency costs by overseeing the behavior of major shareholders and executives of publicly traded companies [7, 1416], which improve company performance and increase corporate value, as they have the advantages of abundant capital, high shareholding ratio, abundant information channels, and strong investment and research teams [17]. (2) However, others argue that institutional investor holdings have a harmful impact on corporate governance. They argue that institutional investors and company executives may work together to diverge from the goal of increasing business value [1820] as they may be focused on short-term performance measures driven by the financial market, which can easily lead to a variety of issues in the company’s long-term management [20]. (3) Finally, there is a belief that institutional investors are poorly controlled and that their participation has little impact on the value of a company. This view is suggested by Wahal [21] in their analysis of the influence of pension funds’ active participation in corporate governance. Similarly, Pouraghajan et al. [22] stated that institutional investors in developing countries cannot fulfil the function of corporate governance monitoring. Therefore, the literature on the impact of institutional investors’ holdings on firm value lacks consensus. Furthermore, despite several studies investigating the heterogeneity of institutional investors and discovering that securities investment funds, QFIIs, and social security funds differ in their enthusiasm for participating in corporate governance, value selection, or value creation roles, there is limited research on the heterogeneity of institutional investors [4, 2327].

Regulators promote and encourage insurance institutions to undertake long-term investments and lead investment ideas due to the long-term stability of insurance funds. However, there are several concerns in the extant literature that have not been thoroughly investigated. For example, are insurance companies, committed towards making long-term investments? How will the presence of IIIs in a company’s stock affect its value, and should firms be concerned about the presence of insurance institutions in their stock? Similarly, despite insurance institutions’ funds being stable, their use is constrained by compensation and maturity payment obligations. Will insurance companies choose FIFO investments for short-term gain in this case? Is there a difference in value creation and discovery among insurance institutional investors with various investment horizons? This article delves into the impact of insurance institutions’ stock ownership on a company’s value to fill in some of the research gaps on these topics.

This article examines data from insurance institutions investing in Shanghai and Shenzhen A-share listed businesses in the Chinese capital market over the course of 25 quarters, from the first quarter of 2012 to the first quarter of 2018. The samples of companies are classified into two categories based on the investment horizon: long-term shareholding and FIFO. The value selection and value creation models are used to investigate the impact of IIIs’ stock ownership on corporate value. Theoretical analysis and empirical testing are followed by a robustness test and a breakdown of short-term and long-term holdings in this article. The study location was chosen as China for two reasons: First, China has the world’s second-largest insurance market, behind only the United States. Simultaneously, China’s insurance market has been ranked first in terms of growth rate among the top 20 insurance markets in the world from 2011 to 2020. Additionally, Chinese insurance funds’ investments in A-shares accounted for 3.44 percent of the total market value at the end of the third quarter of 2019, and their bond investments accounted for 6.49 percent of the total size of China’s bond market, making them the second largest institutional investor in the Chinese market after public funds. Second, as a growing economy, compared with the developed countries, China’s insurance industry started later but experienced a rapid development in more than twenty years. Therefore, it is necessary to strengthen the insurance investment system as well as the regulatory environment. IIIs investment in China’s largest real estate company, Vanke Group, drew the attention and debate of insurance institutional investors throughout China. Holdings in insurance funds were traditionally deemed as "barbaric funds," and were not desired by corporations. The communities’ dreadful imprint on IIIs has yet to be erased. Therefore, this article uses China as an example to investigate the impact of IIIs’ stock ownership on firm value. This can provide proposals for resolving difficulties and issues and serve as a reference for other countries around the world, particularly emerging economies with insufficient insurance systems [28].

The study discovered the following: Firstly, long-term stock-holding IIIs have both value selection and value creation capabilities. Second, among long-term shareholding IIIs, the value creation function increases in significance with an increase in the period of holding shares. Third, FIFO IIIs have a negative impact on the held company’s value. They do not have the ability to create value, but they do have the ability to select value. The following aspects highlight the contributions of this paper: This paper undertakes a rigorous and in-depth analysis of the impact of IIIs’ shareholding on company value, and rectifies the absence of research on IIIs to some extent. Insurance companies were used as an example by Ge and Weisbach [1] to ascertain whether the financial health of institutional investors has an impact on their investment portfolios. However, despite insurers being major and influential investors, there is little research on the impact of institutional investors on firm value. This study investigates the value selection and creation functions of institutional investors’ holdings on enterprises from both a theoretical and empirical perspectives, and thereby expands previous research on institutional investor heterogeneity.

Second, this paper examines the motivation and ability of insurance companies to create value from both positive and negative motivations, and the characteristics of insurance funds, insurance businesses, new accounting standards, and the impact of various stages of insurance company development on value creation. It examines numerous considerations and choices of insurance fund shareholding on a theoretical level and demonstrates the need for incorporating institutional heterogeneity in more in-depth research of institutional investors’ impact on company value. Theoretical analysis gives a reference point for businesses to assess III motivation.

Third, the value creation role is distinguished from an investment horizon in this study, and it thereby provides an empirical basis for regulatory authorities to encourage long-term holdings by insurance firms on a practical level. This article disproves the notion that insurance funds are "barbaric funds" and provides factual support for Chinese regulators’ long-term investment strategy for insurance businesses. The empirical investigations serve as a foundation and point of reference for the creation of regulations. The focus of this article on the impact of Chinese insurance institutions’ shareholdings on firm value can be useful as a benchmark for other nations, particularly emerging economies.

Theoretical analysis and hypotheses

The value selection function of III

Insurance firms and insurance asset management businesses that invest in stocks are referred to as IIIs. The primary source of funds for IIIs is debt funds derived from policy liabilities. When holding shares, IIIs must assess if investment returns can sustain the operation of insurance businesses [1]. That is, the return on investment should be in line with the needs for profitability, liquidity, and safety. Consequently, whether it is short-term stock holding for profit or long-term stock holding to meet liabilities, insurance institutions must choose firms with investment value. This paper defines value selection as the insurance companies are able to select companies with development potential that will grow in value in the future to benefit shareholders. Many studies have revealed that institutional investors, including IIIs, have the ability and inclination to choose value. Studies such as Aggarwal et al. [29], Li and Li [19], Mu and Zhang [30], Shi and Li [31], and Wu and Jiang [32] have demonstrated that ratio of institutional investors’ shareholding, and indicators like firm performance and market value have a substantial positive link. According to Wang and Ge [33], the shareholding ratio of life insurance businesses is substantially connected with the operating success of publicly traded companies. Wen and Feng [34] pointed out that securities’ investment funds are under pressure to frequently publish investment results while discussing the relationship between heterogeneous institutions and independent innovation. However, as insurance funds are exempt from disclosing their investment portfolios on a regular basis and from participating in general fund rankings, they are incentivized to seek out more creative businesses to invest in. The ability of insurance institutions to select value is very clearly demonstrated in practice. The real estate industry, which was traditionally seen as a safe investment by insurance capital in China, was quickly abandoned by the end of 2021 as the real estate environment deteriorated and affected revenue. IIIs considered real estate businesses as "sweet pastry" in the past because of their high return on equity (ROE) and low volatility, and features such as value and growth. The insurance industry also intersects with the real estate market in terms of pension real estate. However, IIIs withdrew their money rapidly when the period of huge payouts in the real estate business ended. Therefore, choosing organizations that are worthy investments is an unavoidable requirement for insurance companies. In addition, insurance funds in China’s capital market are huge in scale, have a lot of information channels, and have good screening skills [17]. This aids in value selection. Insurance institutions’ shareholding scale continues to rise in the Chinese market, with the percentage of investments in the A-share circulating market rose from 3.6% in 2016 to 5.45 percent in 2018. The amount of money that insurance funds invested in stocks and securities accounted for 12.39 percent of the total at the end of the first quarter of 2019. This growth has been fueled in part by the China Banking and Insurance Regulatory Commission’s suggestion to insurance funds to grow their equity holdings in publicly traded companies. Thus, insurance institutions have a great screening power to select desirable enterprises for investment based on government assistance and their own strength.

Based on the above analysis, this paper proposes the following first hypothesis:

Research hypothesis H1: IIIs with long-term or short-term shareholding have the ability to choose value, that is, the shareholding ratio of IIIs has a significant positive impact on company value.

The value creation function of FIFO IIIs

Value creation refers to the increase in the value of the company held by the insurance company after the insurance company holds shares or increases their original holdings. The question of whether IIIs have a value creation function needs to be investigated further, and any discussion of this topic must take into account the holding term of IIIs. Institutional investors may have various long- and short-term goals, concerns, and effects on firm value. In this article, institutional investors who hold short-term equities are referred to as FIFO institutional investors, which signifies that these funds withdraw their money from stocks after a short period of time. Many studies suggest that institutional investors with short-term stock holdings are less motivated to conduct corporate monitoring tasks, and that they anticipate corporate agents to prioritize present success over long-term value, resulting in them being value selectors rather than value producers [23, 29]. Thus, for example, management may cut R&D expenditures in a firm with a high proportion of short-term institutional investors’ holdings to avoid a decrease in the stock price [35]. Therefore, FIFO investors take on the role of short-term speculators, and often take the negative option of "voting with their feet" if they are displeased with the company’s performance [36].

Insurance funds are characterized as the “stabilizer” of the capital market because of their unique benefits of huge scale, steady sources, and the pursuit of secure income. Thus, countries urge insurance funds to make long-term investments to support the capital market’s stability. However, short-term holdings, are appealing to insurance firms as policyholder obligations are the primary source of insurance funding. Property insurance companies, for example, are generally short-term businesses, with insurance periods ranging from one day to one year. Short-term stock holdings make it easier to meet insurance firms’ liquidity needs for insurance claims or maturity payments According to the extant literature, short-term IIIs’ stock investments are short-sighted, and thus cannot improve company performance [3740]. Furthermore, insurance businesses have a limited risk tolerance, and even short-term investments tend to diversify to achieve consistent but poor returns. Additionally, they have a low motivation and ability to participate in corporate governance [27, 41].

Based on the above analysis, this paper proposes the second hypothesis:

Research hypothesis H2: FIFO IIIs do not have the function of value creation, that is, FIFO IIIs’ shareholding changes have no positive relationship with company value changes.

The value-creating function of long-term equity-holding IIIs

The value-creating function of long-term holding institutional investors has been researched extensively in the literature (including IIIs). Institutional investors that hold a firm’s stock for a longer period of time can provide ongoing and effective oversight and help the company operate better [42]. Long-term and heavy-holding institutional investors have a beneficial governance effect on the holding company, as demonstrated by Borokhovich et al. [43] and Brickley et al. [44] from the anti-takeover proposal, Bushee [35] from the investment decision of R&D expenses, and Almazan et al. [45] and Hartzell and Starks [46] from the standpoint of CEO remuneration, respectively. Chen et al. [23] used corporate Mergers and Acquisitions (M&A) decisions to reflect the degree of shareholder supervision over executives, and empirical research found that when a company faces difficulties, its long-term institutional investors usually take positive actions to help it weather the storm, resulting in significantly improved corporate performance. Bamahros and Wan-Hussin [47] showed that that there was an increase in the tendency of investors to provide oversight and promote the company’s long-term worth by acting as a supervisor, with an increase in the holding time.

The impact of insurance institutions’ long-term shareholding on company value is potentially two-sided. Insurance companies have a vested interest in creating value. First, the long-term holding demand of insurance companies and the poor risk tolerance of debt management push them to participate in corporate governance, supervise executives, reduce business agency expenses, and promote corporate value improvement to reap the long-term benefits. Liu et al. [2] evaluated the shareholding characteristics and preferences of insurance organizations and observed that IIIs have a long-term value investing philosophy, which is beneficial to a stable capital market. Second, the healthy development of insurance companies requires support from non-insurance businesses both upstream and downstream. Banks play a key role in the marketing of insurance goods as a part-time insurance agency channel. Insurance companies listing banks will have an impact on bank decision-making, allowing insurance businesses to benefit from synergies. The pharmaceutical and biological industries are inextricably linked to the cost and quality of medical insurance and critical illness insurance provided by insurance companies. The real estate sector is intertwined with the insurance industry’s pension community, as well as pension and long-term care insurance. Furthermore, insurance firms are expected to offer not only current and future pensions, but also limited pension services that can be purchased by pensioners.

The auto sector is inextricably linked to insurance firms’ auto insurance businesses. Insurance companies are expanding their industrial chain in sectors such as pre-sale, after-sale maintenance, daily maintenance, roadside assistance, and vehicle finance. Insurance companies are willing to offer more diverse products and services to their customers, which can increase customer contribution value; insurance companies make full use of the synergies among their various businesses in terms of brands, channels, funds, and so on, which can not only expand the customer base but also increase customer stickiness through cross-selling. To summarize, insurance companies are the final payers in a variety of industries, with a large client base and on-the-ground teams. They have inherent advantages in terms of location as well as significant economic benefits in terms of increasing business boundaries along the industry chain. As a result, we believe that insurance businesses have the desire to create value to benefit from strategic synergy. Third, the new accounting standard IFRS9 (International Financial Reporting Standards), has been fully implemented from 2021, and insurance companies are eager to boost long-term equity investment to reduce profit volatility. Equity assets must be valued at fair value under the new standard, and equity changes will be directly reflected in the income statement, and thus have a rather considerable influence on net profit. According to IFRS9, investments holding more than 5% of a company and a director seat can be included in the long-term equity investment account, which is accounted for using the equity method, so that investment performance is not affected by stock price fluctuations and is more stable. This has an impact on the evolution of insurance fund investment behavior toward long-term value generation to some extent.

Long-term IIIs, on the other hand, have negative incentives to build value, as creating value for companies necessitates an investment of time and money. Since insurance funds are commercial capital, they have no obligation to produce value for other businesses. The benefits of value creation does not always outweigh the expenses. Second, insurance companies are "stress-sensitive" institutional investors [23], as insurance companies and investee companies have commercial links [48], such as offering insurance services [49]. They are concerned that their own oversight and involvement in the enterprise’s management may result in the loss of existing or potential commercial contracts and impact their own income. Therefore, the cost of performing its supervisory function is higher for insurance companies than for other pressure-resistant institutional investors (funds, social security funds, QFII, enterprise annuities), and it lacks the motivation to actively participate in corporate governance [50], making it difficult to contribute to the creation of value for businesses. Third, the insurance industry’s development and asset management are still in their infancy; there are variances in the development of insurance institutions, and not every insurance business is at the stage of expanding the insurance industry chain. Short-sighted behavior and the objective development stage are highly likely to result in no value generation function.

Based on the above analysis, this paper proposes a third hypothesis:

Research hypothesis H3a: Investors in long-term holding type insurance institutions have the function of value creation, which means that increases in their shareholding have a positive impact on the company’s value changes.

Research hypothesis H3b: Long-term holding type insurance institutional investors do not have the function of value creation, i.e., shareholding changes of long-term holding type insurance institutional investors have no substantial association with changes in the company’s value.

Model design and variables

Main research model design

Given that IIIs’ decision to buy stocks in period t is based on the company’s value performance in period t and before, and that IIIs’ ability to choose value is reflected in the company’s performance after period t (where t represents time; since the data used in this article spans quarters, t represents a quarter, where t = 1, 2, 3… . 25). Furthermore, there may be a strong relationship between insurance institutions’ shareholding ratio and company value: insurance institutions’ participation in corporate governance may promote better value performance of the company; and companies with high value are more likely to be favored by insurance institutions, who then take stakes in the company. This suggests that, to some extent, the shareholding ratio of insurance institutions and firm valuation are causally related, which could cause endogeneity issues in the model. Based on the two reasons above, a more reasonable model to evaluate the value selection function of insurance institutions is to utilize the t-period III’s shareholding to regress the company value in t+1 period.

Based on the foregoing assumptions, we use the business value as the explained variable and the shareholding ratio of IIIs with a lag period as the explanatory variable to evaluate the first hypothesis of this study, namely, whether IIIs have the role of value selection. In this paper, the value selection model is created using the following linear regression model:

ComValuejit=βj1*L.Sharehjit+βj2*Controljit+αji+ϑjt+εjit (A)

where ComValuejit is the value of listed company i in period t; Sharehjit is the shareholding ratio of listed company i in period t; Controljit is the control variable; αji and ϑjt are the sample companies’ individual and time effects, respectively; and εjit is random error. Furthermore, j = 1, 2, with 1 denoting long-term stock holding IIIs, and 2 denoting FIFO IIIs. L. in model(A) represents the first-order lag operator, and the one-period lag is used because the proof of the value selection ability of IIIs requires a certain period of time to test, which has a lag; however, the endogeneity problem can be solved to a certain extent. The value selection model (A) is primarily utilized to see if the IIIs presented in Hypothesis 1 have a value selection function.

We use the change in company value (D. ComValuejit) as the explanatory variable and the stock holdings of IIIs as the explained variable to test the second and third hypotheses of this paper, namely, whether IIIs have a value-creating function. The change in the shareholding ratio of insurance institutions (D.Sharehjit) is employed as an explanatory variable in the value creation model that follows (B):

D.ComValuejit=γj1*D.Sharehjit+γj2*Controljit+αji+ϑjt+εjit (B)

What needs to be clarified in model (B) is the meaning of D., which stands for the first-order difference operator, especially:

D.ComValuejit=ComValuejitComValuejit1
D.Sharehjit=SharehjitSharehjit1

Model (B) is utilised as a model for evaluating value creation because even if Model (A) is constructed, it can only determine the value selection function of IIIs; however, determining whether IIIs have a value creation function is challenging. Model (B) must establish the explained variable as a difference operator to observe the improvement of the company’s value to test if the III’s shareholding may help enhance the company’s worth. Changes in the shareholding ratio of insurance institutions are also used as explanatory variables in model (B), primarily for two reasons: Changes in insurance institutions’ shareholding ratios can reflect their preferences at a given time—buying or selling stocks is an important way for insurance institutions to participate in corporate governance and influence the value of companies, referred to as "voting with hands" and "voting with feet".

This paper determines the indicators to measure the company’s value after establishing the models (A) and (B). Most studies, like those by Cornett et al. [51], Ferreira and Matos [52] and Healy [53], employ Tobin’s Q [54] value to evaluate firm value, but China’s stock market’s price discovery function is in a nascent stage, and there is a strong speculative atmosphere. It is difficult to determine the true worth of publicly traded companies based on Tobin’s Q [54]. Therefore, this article selects three measures to estimate the value of organisations after meticulous screening. Our first indicator, based on Chaganti and Damanpour [55] and Tang and Song [27], chooses earnings per share (EPS) as the key explanatory variable. Second, two alternative proxies, return on assets (ROA) [51, 56] and return on equity (ROE) [19, 57], are utilised as robustness test indicators. The parameters βj1 and γj1 test the value selection and value creation functions of IIIs, respectively, where j as mentioned previously, takes 1 for long-term shareholding IIIs, and 2 for FIFO insurance institutional investment. The estimated parameters β11 and β21 are expected to be positive under assumption H1, and γ21 is expected to be negative or insignificant under assumption H2, implying that FIFO IIIs do not have the function of value creation; the parameter γ11 is expected to be positive under assumption H3a, but γ11 is expected to be negative or insignificant in H3b.

Selection of instrumental variables

There are two types of endogenous difficulties that frequently arise during the estimation of panel models: (1) It is difficult to quantify the effect of factors related to IIIs on the value of the held company, such as measurement errors and omitted variables; (2) The value of the held company and the holdings of IIIs could have a reverse causal relationship. This study addresses three aspects of the first type of endogenous problem: First, it improves the data and restores the data’s legitimacy. This work does not employ databases to handle the problem of missing data, and instead combines the three major databases of WIND, CMSAR, and RESSET to collect complete sample data. Secondly, it selects an acceptable model estimation approach. The data in this research is balanced panel data, and we use the panel data to develop a fixed effect model. The fixed effect model can ignore the influencing factors of individuals that do not change with time such as corporate culture, company creation date, corporate character, and other factors. Thirdly, it incorporates control variables. To limit the interference of residuals on the shareholding ratio, control factors such as the company’s growth, capital scale, and so on are introduced to the model.

This paper uses the lagging one period of the shareholding ratio of insurance institutions as the explanatory variable for constructing the value selection model in the model design to mitigate the negative impact of company value on the shareholding ratio of IIIs in the second type of endogenous problem. Some researchers have utilised the turnover rate of tradable shares as an instrumental variable of institutional investors’ ownership ratio in the past literature [27], however this indicator is not appropriate for the IIIs analysed in this article. Instrumental variables must meet two conditions: they must be strongly correlated with endogenous variables, and must not be correlated with model disturbances. The stock turnover rate does not match the first criteria, because it has a very weak link with the shareholding ratio of IIIs. The correlation coefficient between the overall turnover rate and the shareholding ratio is nearly 0, and the correlation coefficient between the outstanding share turnover rate and the shareholding ratio is just 0.012, which is not significant. Relevant data can be requested from the author. Therefore, alternative indicators for instrumental factors must be sought. This paper uses the institutional investor equity concentration of sample companies as a tool variable, that is, the proportion of the top three and top five institutional investors in the invested company (the specific equity concentration recorded as InsFir3 and InsFir5) as an instrumental variable, based on the relevant research results of Demsetz [58] and Demsetz and Lehn [59] in the field of corporate governance and referring to the idea of selecting instrumental variables by Hansen et al. [25]. Simultaneously, the higher-order lag term (L3.EPS and L4.EPS) of the insurance company’s shareholding ratio is used as an instrumental variable to mitigate the problem of weak instrumental variables [60].

The specific equity concentration variables InsFir3 and InsFir5 are employed as the instrument variables of the III’s shareholding ratio in this research to investigate the hypothesis that "the ownership structure has nothing to do with the company’s success". According to some academics, the ownership structure will have an impact on the company’s performance because of the principal-agent problem generated by the separation of the two sets of rights [6164].

Demsetz [58], on the other hand, questioned the above-mentioned viewpoints, and asserted that the company’s shareholding structure is the game’s equilibrium conclusion after each player analyses the advantages and negatives to maximize their personal interests. Thus, the company’s overall ownership structure has little impact on its success. Although the separation of control and ownership can cause principal-agent difficulties [63], it can also aid in increasing the quantity of the funds obtained by extending the company’s scale, and improve the company’s operating efficiency by increasing the degree of professional specialization (i.e., separation of capital providers from professional agents). The advantages of separating control and ownership are counterbalanced by the potential risks. Therefore, the equity structure has no bearing on the company’s performance as otherwise, there would not be a significant variety in the equity arrangements of companies in the long run [25].

The rationale for the instrumental variables in this paper is as follows: First, the fixed effect model controls the disturbance that a company’s individual heterogeneity has on the individual heterogeneity of the stock structure of institutional investors within the holding business by partially excluding the company’s individual effect. Second, even if there are endogenous concerns in institutional investor ownership concentration (Insfir3, Insfir5) in the instrumental variable sample firm [59], the ownership structure is mostly influenced by the company size, profitability, and industry. Including control variables, such as firm size, improves the usefulness of instrumental variables to a certain degree in the model. Third, using ownership concentration degree as a control variable further reduces the mutual disturbance between residuals from the model and instrumental variables by controlling for important information from institutional investors who are also significant shareholders. Fourth, the number of instrumental variables outnumbers the number of explanatory variables that are endogenous as over-identification is more successful in large samples [65]. The validity of instrumental variables can be verified using methods such as the Sargan test, which also happens to identify a test method that does not yet exist in the case of over-identification. Fifth, meet the necessary instrumental variable test standards, such as the identification test, weak instrumental variable test, and so on.

Model design for counterfactual testing

This paper creates a counterfactual test model to check the reliability of the model conclusions to examine whether the model’s inherent flaws are effectively controlled. Theoretically, IIIs’ future shareholding should have no impact on the existing holding company’s performance. When the parameters βj1 and γj1 to be estimated are significant in the measurement model constructed by the future shareholding ratio, the information about the insurance company’s equity structure indicators and the held company’s performance is still in the model’s disturbance terms, and as an instrumental variable, it does not effectively solve the model’s endogeneity. Similarly, when they are not significant, the endogenous problem in the model is effectively controlled to some extent. The following counterfactual testing models (C) and (D) are based on this concept:

L2.ComValuejit=βj1*L.Sharehjit+βj2*L2.Controljit+αji+ϑjt+εjit (C)
L2.(D.ComValuejit)=γj1*D.Sharehjit+γj2*L2.Controljit+αji+ϑjt+εjit (D)

L2. in (C) and (D) represents the second-order lag operator, which lags the explanatory variable by two periods. Except for the shareholding ratio of IIIs and their shareholding changes, which are the same as in models (A) and (B), the rest of the control variables are lagged by two periods to verify the relationship between future and current shareholding, and to conduct repeated counterfactual tests of the relationship between performances in formulas (C) and (D).

Data

Data processing

Sample period

The sample period for this study is from the first quarter of 2012 to the first quarter of 2018, and the research objects for empirical research are A-share listed companies on the Shanghai and Shenzhen stock markets in China. The data is collected on a quarterly basis, with a total of 25 quarters. Furthermore, while calculating the holding duration of IIIs, the first quarter of 2010 is used as the starting point, implying that the computation of the holding term of IIIs begins in the first quarter of 2010. Despite Chinese insurance funds having entered the capital market long before the subprime mortgage crisis, this paper uses 2010 as the starting point for the calculations because the Insurance Law empowering insurance companies to make equity investments was promulgated in 2009. According to statistics on publicly traded companies, insurance institutions owned less than 200 publicly traded companies in 2009, with a low shareholding ratio. Thus, this year is excluded, and the calculations begin in 2010 as the effects of ownership was insignificant in 2009.

The data shows that as of the end of the first quarter of 2018, there were less than ten companies where insurance companies held shares for periods of more than 20 quarters (5 years). This indicates that our calculation of shareholding periods since 2010 essentially covers the shareholding cycle of all companies held by insured institutions, and validates the starting point and the sample’s integrity.

The period between 2010 and 2011 is not included in the sample as the holdings by insurance companies were not substantial during this period and had a low shareholding ratio and a small scale [27]. Thus, the time period chosen is from the first quarter of 2012 up till the first quarter of 2018. China’s capital market suffered stock market volatility in 2015. The "Vanke-Baoneng Battle" has raised concerns about insurance capital, as has the issue of employing short-term insurance funds for long-term investment by insurance capital. In July 2015, the Baoneng Group’s Qianhai Life Insurance Company purchased Vanke shares on the secondary market, amounting for 5% of the company’s total share capital. Baoneng, working with Qianhai Life Insurance, Jushenghua, and other parties through multi-party activities, exceeded China Resources Group, Vanke’s original largest shareholder, for the first time in less than a month, and suggested calling an extraordinary general meeting to recall all directors. At the same time, Vanke used a private placement to introduce its shareholder Shenzhen Metro Group to pay the consideration. The probe has included the China Securities Regulatory Commission and the Shenzhen Stock Exchange. Shenzhen Metro Group eventually became the largest shareholder, Baoneng gradually withdrew from the competition, the former chairman of Vanke stepped down, and the war between Vanke and Baoneng came to an end. The sample in this research spans the three-year sample period before and after 2015, yielding a relatively complete capital market cycle. A balanced panel data sample with the data format "company-quarter" covering a total of 25 quarters for this study.

Data resource

The model’s economic indicator data originates from three primary databases: WIND, CMSAR, and RESSET, as well as some companies’ quarterly financial reports. The RESSET database is primarily used to calculate financial metrics such as company growth, capital structure, and scale. At the same time, missing data is filled using WIND, CMSAR databases, and quarterly financial reports. If a sample’s missing observation data is greater than 3/5 of the sample time zone’s length, the sample will be removed immediately. The limits will be eased as far as practicable if the company has insurance institutional investors holding shares. Interpolation (average of the upper and lower periods of missing data) and observation were used to fill up the gaps. Because the number of listed firms held by insurance companies in the early stages is quite limited, and missing data on the shareholding ratio is particularly serious, the goal is to keep as large a sample of listed companies held by insurance institutional investors as possible. The data of the shareholding ratio of IIIs originates from CMSAR database. The missing pieces are primarily from databases such as WIND. Data on the shareholding ratio of some insurance institutional investors is not disclosed at the end of the quarter, but rather at various intervals throughout the year. This study uses sample observations from the most recent release before the conclusion of the quarter to assure the data’s richness. Other non-financial variables are considered in the same way as their end-of-quarter proxy value. Between the WIND database and the other two databases, there is a significant gap. This article is only intended to fill in the missing data for reference purposes, in order to ensure the data’s richness and accuracy.

Data processing

This paper excludes abnormal samples such as "ST" and "*ST" shares, as well as the sample of financial companies, which yielded 1,654 samples. If a listed company’s financial state or other conditions are anomalous in China’s capital market, the Shanghai and Shenzhen Stock Exchanges will give the listed company’s shares special treatment. This form of stock is known as ST stock because of the "special treatment" it receives. If a stock’s name is prefixed with ST, it carries investment risk; if *ST is added, it has the danger of being delisted. The firm samples are then separated into two categories based on their investment horizon: long-term shareholding type and short-term shareholding type, with the latter being referred to as FIFO type in this article. The III shareholding period indicator (InsDura) is calculated as follows: From 2020 onwards, we will calculate whether a publicly traded firm is owned by insurance institutions. If the frequency is based on quarter, there are a total of 33 intervals of quarterly period tj from the first quarter of 2010 to the end of the first quarter of 2018. If the stock of listed company i is held by IIIs in a specified interval tj (j = 1, 2…, 33), the variable (yes_noIns) associated with tj will be marked 1. Conversely, if no insurance institution holds shares of the listed company i in a given interval tj, the variable (yes_noIns) corresponding to the listed company i in that interval tj is set to 0; then the interval in which 1 appears in the sample individual i consecutively is set to mik (where k = 1,2…,n, where n is the maximum number of consecutive intervals), and then the consecutive terms mik are added together, and recorded as tij. As a result, the holding duration of IIIs is as follows:

InsDuraf(i)={tij,IfthesampleindividualiintheintervalisheldbyIIIs;0,elsewhere

The average holding time of the selected sample by insurance firms is 6.9 quarters, according to the aforementioned method. Elyasiani and Jia [66] divided the long-term and FIFO samples based on whether it was greater than the index mean. This work addresses the symmetry of the long and short multiples to assure the sample’s adequacy while also distinguishing the structural characteristics of the holding duration. IIIs with more than 1.25 times the average holding time (greater than 9 quarters) are considered long-term holding types in this paper, while those with less than 0.75 times (less than 6 quarters) are considered FIFO holding types. The ratio is set at 1.5 times and 0.5 times, respectively, in the robustness test, i.e., more than 11 quarters are recorded as longer-term holdings, and less than 4 quarters are recorded as shorter-term holdings.

Descriptive statistics

The explained variable is the firm value (expressed by EPS, ROA, and ROE), and according to Cornett et al. [51], the key explanatory variable is the shareholding ratio of IIIs. Table 1 shows the detailed definitions. The control variables in the model include: (1) Corporate governance structure (Conc), which is measured by the company’s ownership concentration. According to previous research literature, firm value does not alter ownership structure, and hence there is no reverse causal relationship between ownership structure and company value [27, 6769]. The mutual interference between the model residual and the ownership structure can be moderately reduced if the control variable includes the ownership structure index, which improves the effectiveness of the institutional investor ownership concentration (Insfir3, Insfir5) as an instrumental variable. (2) Company growth (Grow), following Aggarwal et al. [29], this work controls for the company’s growth as it may have an impact on its value. (3) Financial leverage (AssLia). An asset-liability ratio is selected to measure the impact of financial leverage as financial leverage has an influence on firm value [70, 71]. (4) company size (Size). The impact of company size is factored into the model as a great number of studies have shown that company size has an impact on the company’s value. (5) Institutional investor heterogeneity (NonIns). The characteristics of shareholders impact firm value, according to Huang et al. [54], Tang and Li [71], Song et al. [72] and Li et al. [73], thus, this article addresses the impact of non-IIIs. (6) The lag term (PreValue) of the company’s value measurement variable is also measured as it may be more difficult to enhance the performance of listed firms with high value. Thus, the previous period’s company value is introduced as a control variable to models (A) and (B) to mitigate the endogenous problem [27, 41]. Higher-order lag terms (L3.ComValue and L4.ComValue) are likewise considered as instrumental variables [41, 60].

Table 1. Variables definitions.
Index sign Index meaning Index name and calculation method
Explained variables EPS The proxy variable to measure the value of a company Eearningspershare=Currentnetprofitattributabletocommonshareholders(Numberofoutstandingcommonshares*portionofthereportingperiodthosesharescovered)/12
ROA ReturnonAssets=NetIncome(includingminorityinterests)*2initialtotalassets+endingtotalassets*100%
ROE
Returnonequity=Netprofitattributabletoparentcompanyshareholders*2Initialequityattributabletoshareholdersoftheparentcompany+endingequityattributabletoshareholdersoftheparentcompany
Explanatory variable Shareh Shareholding ratio of IIIs The proportion of institutional investors (insurance companies) holding outstanding shares of listed businesses, according to data from the Wind, RESET, and CMSAR databases.
Control variable Grow Company growth Growthrateearningspershare=earningspershareofthisquaterearningspershareofpriorquaterearningspershareofpriorquarter*100%
AssLia Capital Structure Financial Leverage Asset-liability ratio = Total liability/total assets
Size Company scale Logarithmic total assets = natural logarithm of total assets
Conc Corporate governance structure Ownership concentration = The total shareholding ratio of the top three shareholders
NonIns Control institutional investors’ heterogenous difference Shareholding ratio of non-insurance companies = sum of shareholding ratios of non-insurance investors including four major institutional investors, namely, funds, security financial products, banks and pension funds.
PreValue Company value in the previous period The company value of the listed company in the previous period is L.ComValue in model (A) and L2.ComValue in model (B). PreValue corresponds to three indicators of company value: EPS, ROA, ROE

All variables are winsorized by 1 percent and 99 percent in this work to eliminate the influence of outliers on the model. Table 2 presents summary statistics for the variables. Panel A shows that long-term and FIFO III shareholding ratios are roughly 1.7417% and 0.2414%, respectively, with long-term investors having the greatest shareholding ratio of 58.820%. FIFO investors had the highest shareholding ratio at 21.820%. The ratio of the total shareholding ratio of insurance institutional investors to the total number of quarters is used to calculate the average shareholding ratio of insurance institutional investors. If the quarters with a zero-shareholding percentage are omitted, the overall sample’s average shareholding ratio is around 2.5 percent. In addition, Panel B shows the shareholding ratio and shareholding term of insurance institutions under various company values after grouping company value EPS according to the average value. The mean shareholding ratio and holding term of insurance institutions are significantly higher in the group with higher company value (EPS> = median) than in the group with lower business value (EPS<median). It is first demonstrated that IIIs have a value selection function.

Table 2. Summary statistics.
Panel A                                                              Long-term holding
Index EPS ROA ROE Shareh Insfir3 Insfir5 Grow AssLia Size Conc NonIns
Number of samples 8700 8700 8700 8700 8700 8700 8700 8700 8700 8700 8700
Mean 0.4671 4.6927 5.3377 1.7417 0.8857 1.3346 15.8804 47.4281 2.0051 49.8864 6.2176
Standard deviation 0.5216 5.3864 5.8877 4.077 3.2786 3.7656 96.4969 19.5290 0.6158 16.6336 7.8271
Minimum -0.8344 -29.4725 -10.54 0 0 0 -235.300 7.7649 0.2612 8.4986 0
Median 0.3553 3.8896 4.08 0.33 0 0 7.5449 47.0514 1.9206 50.2304 3.585
Maximum 2.2213 46.3117 21.4900 58.82 36.3737 46.8682 324.8260 86.358 4.3885 98.3571 102.762
                                                                                                      Fast in and fast out
Number of samples 19500 19500 19500 19500 19500 19500 19500 19500 19500 19500 19500
Mean 0.2851 3.7367 4.1145 0.2414 0.0617 0.1215 18.1226 42.9522 1.6296 47.5812 4.9567
Standard deviation 0.4033 5.8575 5.784 0.8611 0.5594 0.6989 114.5397 21.5781 0.5117 15.18 7.7091
Minimum -0.8344 -29.4725 -10.54 0 0 0 -235.294 3.8217 -0.598 0.5648 0
Median 0.2157 3.2157 3.05 0 0 0 5.1728 41.8841 1.5647 46.9198 1.9931
Maximum 2.2213 46.3117 21.49 21.82 18.75 18.75 324.826 92.1799 3.4195 97.53 96.6152
Panel B EPS> = median EPS<median Difference
Long-term holding
Mean Mean Mean
Shareholding ratio 2.0480 1.4864 0.5616***
Holding period 4.5037 3.1912 1.3125***
Fast in and fast out
Shareholding ratio 0. 2792 0. 1858 0.0934***
Holding period 0.3247 0.2364 0.0883***

Model regression analysis and counterfactual testing

Correlation test

In this paper, each variable is correlated, and the correlation coefficient matrix is provided in Table 3. The correlation between the major variables is poor except for the three types of corporate performance indicators, which includes EPS, ROA, and ROE. The remaining variables’ correlation coefficients are almost all below 0.5, indicating that the model does not have severe multicollinearity issues. The correlation coefficients between the insurance shareholding ratio and the company value index are 0.122, 0.037, and 0.055, respectively, indicating a positive association between the insurance shareholding ratio and the company value. Simultaneously, economic variables such as company value measurement indicators, shareholding ratio of IIIs, and shareholding concentration all reject the existence of unit root at the 1% or 5% significant level, based on the panel unit root tests such as the Levin-Lin-Chu (LLC) test [74].

Table 3. Pearson correlation coefficient.
Index EPS ROA ROE Shareh Grow AssLia Size Conc NonIns
EPS 1
ROA 0.711*** 1
ROE 0.594*** 0.567*** 1
Shareh 0.162*** 0.067*** 0.087*** 1
Grow 0.197*** 0.200*** 0.342*** 0.007 1
AssLia -0.095*** -0.326*** -0.084*** 0.011* 0.011* 1
Size 0.224*** -0.064*** 0.128*** 0.119*** 0.049*** 0.518*** 1
Conc 0.161*** 0.094*** 0.126*** -0.033*** 0.003 0.040*** 0.276*** 1
NonIns 0.278*** 0.255*** 0.265*** 0.086*** 0.059*** -0.127*** -0.049*** -0.035*** 1

Note: Table 3 preserves three decimal places since the correlation coefficient has only three decimal places.

Model regression analysis

The data generated in this paper is strongly balanced panel data (firm-year panel). We adopt a fixed effect model for model regression following Aggarwal et al. [29] and Massa et al. [75]. This is for a number of reasons: First, from an economic standpoint, omitted variables, such as corporate culture, executive characteristics, and so on, are often difficult to quantify, and "heterogeneous" differences in companies, which are difficult to observe and measure, frequently lead to serious endogenous problems. The fixed-effect model can lessen the endogenous problem produced by the bias interference of omitted variables as the differential process in the estimated approach of the fixed-effect model can eliminate "time-invariant" firm heterogeneity to some extent. Second, this paper used statistical analysis such as the F test and the Hausman test from a statistical standpoint. The results reveal that at a 1% significance level, the fixed effect model is the most appropriate. The author may provide F test data upon request, and the values of Hausman test statistics can be found in Table 4. The Two-Stage Least Squares (2SLS) estimation results are used in this paper for the long-term holding type and the fast-in-fast-out type; simultaneously, the Limited Information Maximum Likelihood estimation (LIML) method, which is insensitive to weak instrumental variables, is used to obtain the model parameters. The reasonableness of the instrumental variable selection is indirectly validated if the difference between the two estimations is minimal. Thirdly, we diagnose the model residuals and draw a scatter plot of residuals and model fitting values at the same time, demonstrating that the model has no heteroscedasticity problem. Similarly, since the Generalized Method of Moments (GMM) regression method is suitable for the case where the model has heteroscedasticity, the GMM estimation method is not used in this paper. The regression results of the GMM method are available to the readers upon request. The regression findings are as follows: the value selection model results correspond to model (A), and hypothesis 1 is tested, as shown in Table 4. The value creation model’s outcomes correlate to model (B), as shown in Table 5. Columns (3) and (4) of Table 5 tests hypothesis 2 and determines whether FIFO IIIs have a value creation function. The results in columns (1) and (2) test hypothesis 3 and determine whether long-term shareholding insurance institutions are value creators or value suppressors.

Table 4. Value selection model (the explained variable is earnings per share:EPS).

Variable Long-term holding Fast in and fast out
IV (LIML) (1) IV (2SLS) (2) IV (LIML) (3) IV (2SLS) (4)
L. Shareh 0.00463*** 0.00463*** 0.00509* 0.00509*
(0.00145) (0.00145) (0.00278) (0.00278)
L.EPS 0.56547*** 0.56546*** 0.52198*** 0.52199***
(0.04151) (0.04150) (0.04915) (0.04914)
Grow 0.00068*** 0.00068*** 0.00065*** 0.00065***
(0.00003) (0.00003) (0.00002) (0.00002)
AssLia -0.00020 -0.00020 -0.00057* -0.00057*
(0.00039) (0.00039) (0.00034) (0.00034)
LogAss -0.06924** -0.06924** 0.02408 0.02408
(0.03287) (0.03287) (0.01920) (0.01920)
Conc 0.00117* 0.00117* 0.00014 0.00014
(0.00061) (0.00061) (0.00040) (0.00040)
NonIns 0.00186*** 0.00186*** 0.00230*** 0.00230***
(0.00043) (0.00043) (0.00038) (0.00038)
Industry variables Controlled Controlled controlled controlled
Joint significance 40.96*** 40.96*** 118.71*** 118.72***
Under-identification 1027.685*** 1027.685*** 175.280*** 175.280***
Weak instrumental variables 1681.579/ 199.382 1681.579/ 199.382 3121.977/ 38.021 3121.977/ 38.021
Hansen J 3.054 3.054 3.652 3.652
Hausman 199.49*** 2459.68***
Number of Observations N 8715 8715 19500 19500

Note: The joint significance of the time dummy variables is referred to as joint significance. The symbols "*," "**," and "***" in the table indicate that the statistic is significant at the 10%, 5%, and 1% levels, respectively. "In the first-stage regression, the instrumental variables utilized have no explanatory power for endogenous variables," is the null hypothesis of the under-identification test, and the value of the under-identification test in this work considerably rejects the null hypothesis. The Cragg-Donald Wald (CD) statistic and the Kleibergen-Paap (KP) statistic are both weak instrumental variable tests. Stock et al [76] argue that even if instrumental variables pass the under-identified test, they may still exhibit "substantial distortion" (size distortion). Hence the Stock-Yogo statistic is based on this assumption. It is more difficult to reject the null hypothesis—"the instrumental variable is strongly correlated with the endogenous variable"—when the KP value is greater than the Stock-Yogo statistic value. Since the KP value in this paper is greater than this value, it can be ascertained that there is no weak instrumental variable problem. The results of the over-identification test were reported by Hansen J. The number of instrumental factors in this study exceeds the number of endogenous variables, meeting the over-identification test’s assumption. The results of Hansen J are not significant, and the basic hypothesis that "all instrumental factors are exogenous" is not rejected, which also reveal the logic behind the selection of model instrumental variables. This also applies to Table 5.

Table 5. Value creation model (the explained variable is the change in earnings per share, namely: D.EPS).

Variable Long-term holding Fast in and fast out
IV (LIML) (1) IV (2SLS) (2) IV (LIML) (3) IV (2SLS) (4)
D.Shareh 0.0168** 0.0167** -0.0081* -0.0080*
(0.008) (0.008) (0.005) (0.005)
L2.EPS -0.1920*** -0.1919*** -0.2310*** -0.2310***
(0.016) (0.016) (0.014) (0.014)
Grow 0.0006*** 0.0006*** 0.0005*** 0.0005***
(0.000) (0.000) (0.000) (0.000)
AssLia 0.0003 0.0003 -0.0003 -0.0003
(0.000) (0.000) (0.000) (0.000)
LogAss -0.0659** -0.0659** -0.0170 -0.0170
(0.031) (0.031) (0.015) (0.015)
Conc -0.0004 -0.0004 -0.0002 -0.0002
(0.001) (0.001) (0.000) (0.000)
NonIns 0.0008** 0.0008** 0.0008*** 0.0008***
(0.000) (0.000) (0.000) (0.000)
Industry variables controlled Controlled controlled controlled
Joint significance 28.60*** 28.61*** 49.38*** 49.38***
Under-identification 86.749*** 86.749*** 219.641*** 219.641***
Weak instrumental variables 56.126 / 20.382 56.126 / 20.382 455.985 / 55.634 455.985 / 55.634
Hansen J 0.282 0.282 3.288 3.288
Hausman 693.99*** 2548.53***
Number of samples N 8715 8715 19500 19500

Note: The joint significance of the time dummy variables is referred to as joint significance. The symbols "*," "**," and "***" in the table indicate that the statistic is significant at the 10%, 5%, and 1% levels, respectively. "In the first-stage regression, the instrumental variables utilized have no explanatory power for endogenous variables," is the null hypothesis of the under-identification test, and the value of the under-identification test in this work considerably rejects the null hypothesis. The Cragg-Donald Wald (CD) statistic and the Kleibergen-Paap (KP) statistic are both weak instrumental variable tests. Stock et al [76] argue that even if instrumental variables pass the under-identified test, they may still exhibit "substantial distortion" (size distortion). Hence the Stock-Yogo statistic is based on this assumption. It is more difficult to reject the null hypothesis—"the instrumental variable is strongly correlated with the endogenous variable"—when the KP value is greater than the Stock-Yogo statistic value. Since the KP value in this paper is greater than this value, it can be ascertained that there is no weak instrumental variable problem. The results of the over-identification test were reported by Hansen J. The number of instrumental factors in this study exceeds the number of endogenous variables, meeting the over-identification test’s assumption. The results of Hansen J are not significant, and the basic hypothesis that "all instrumental factors are exogenous" is not rejected, which also reveal the logic behind the selection of model instrumental variables

The numbers in this paper’s table are rounded to four decimal places, however Table 4 is rounded to five decimal places because the LIML and 2SLS findings only differ in the fifth decimal place. Tables 4 and 5 show that the instrumental variables chosen by the model are statistically appropriate. Concerning the problem of weak instrumental variables, LIML’s conclusions in the two tables are essentially identical to the 2SLS estimation results, and the CD value and KP value of the weak instrumental variable test are both greater than the critical value of 10, indicating that the model has no obvious weak instrumental variable problem. The Hensen J statistic in the two tables did not reject the null hypothesis of "instrumental variables are exogenous" in the over-identification test, showing that instrumental variable selection is statistically sensible. Furthermore, the Hausman statistic demonstrates that the fixed-effect model is superior to the random-effect model, validating the rationale of using fixed effects in this paper.

The findings of the value selection model (A) are shown in Table 4. The shareholding ratio coefficient β11 (0.00463) of insurance institutions was significantly positive at the level of 1% for long-term shareholders in the preceding period, as shown in the table, and is favourably associated to the company value. β21 (0.00509) is likewise significantly positive at the 10% level for FIFO IIIs. Table 4 shows that the research hypothesis H1 is correct, demonstrating that insurance companies have a value selection function. Long-term shareholding insurance companies are willing to pay a cost to select high-quality companies to generate consistent equity returns. Conversely, FIFO insurance companies will actively use their information collection advantages to find high-quality companies to hold shares.

Table 5 shows the empirical results of the value creation model (B), in which columns (3) and (4) show that FIFO insurance institutions do not have a value creation function, and their insurance institution shareholding ratio coefficient γ21 (-0.0081, - 0.0080) is negative at the 10% significance level, indicating that the impact of changes in shareholdings by insurance institutions on company value is negative, confirming the proposed hypothesis H2. The FIFO III’s shareholding has no positive correlation with the company’s value movements and serves no value creation role.

The results of long-term shareholding insurance institutions are reported in columns (1) and (2) of Table 5. The long-term investor shareholding ratio coefficient γ11 (0.0168, 0.0167) is positive at the 5% significance level, as shown in the table. As a result, hypothesis H3a in the competitive hypothesis H3 is confirmed, i.e., long-term equity-holding IIIs have a value creation function. The main logical premise is that presently Chinese insurance funds have high stability and low fund recovery pressure, and long-term shareholding by insurance funds fully exploits their features and advantages while also promoting the value appreciation of the held company. However, due to its low shareholding ratio and unwillingness or inability to bear the cost of governance, the FIFO type is less involved in corporate governance and instead uses the advantages of information collection to select high-quality companies with high internal governance transparency. Some FIFO IIIs even demonstrated the phenomenon of "investors-retail," which is very similar to the investment goals of short-sighted managers. Conspiracy to boost short-term returns, trigger group speculation, swiftly drive up the stock price and cash out, all of which have a negative influence on value creation and adversely affects the company’s long-term development strategy, is simple to execute. As a result, long-term IIIs have the function of value creation, whereas FIFO IIIs do not.

Counterfactual test

We built models (C) and (D) for counterfactual testing in the preceding discussion [77, 78]. Theoretically, future III shareholding will have no impact on the current holding company’s value, i.e., the shareholding ratio of insurance institutions in period t+1 has no impact on the firm’s worth in period t. The explained variables and key control variables, other than the shareholding ratio of insurance institutions, are lagged two periods in the specified regression model, and the counterfactual test models (C) and (D) were constructed. Table 6 displays the model’s output. The regression findings of the LIML and 2SLS approaches do not differ significantly, as shown in Tables 4 and 5. Thus, we only employ the LIML approach for regression in the following models. Table 6 shows that the parameters βj1 (0.0008, 0.0011) estimated in columns (1) and (2), and γj1 (0.0023, 0.0048) estimated in columns (3) and (4) did not show significance. That is, there is no significant relationship between the shareholding ratio of insurance institutions and the company’s value in the counterfactual value selection model (C) and the counterfactual value creation model (D). These results illustrate that the shareholding ratio of insurance institutions and the corresponding value selection model (A), and the disturbance terms in the value creation model (B) are relatively independent, and that the instrumental variable "institutional investor equity concentration" chosen in this paper can help address model endogeneity more effectively.

Table 6. Counterfactual test model parameter estimation results.

Variable Value selection model Value creation model
Explained variable: EPS (lagged by two periods) Explained variable: (D.EPS) (lagged by two periods)
Long-term holding (1) Fast in and fast out (2) Long-term holding (3) Fast in and fast out (4)
L.Shareh 0.0008 0.0011
(0.001) (0.002)
D.Shareh 0.0023 0.0048
(0.003) (0.004)
L3.EPS 0.7891*** 0.7018*** -0.2105*** -0.2982***
(0.015) (0.015) (0.015) (0.015)
L2.Grow 0.0003*** 0.0002*** 0.0003*** 0.0002***
(0.000) (0.000) (0.000) (0.000)
L2.AssLia 0.0007** -0.0003 0.0006** -0.0003*
(0.000) (0.000) (0.000) (0.000)
L2.LogAss -0.0971*** -0.0317** -0.0949*** -0.0312**
(0.031) (0.014) (0.030) (0.014)
L2.Conc -0.0001 -0.0001 -0.0001 -0.0001
(0.001) (0.000) (0.001) (0.000)
L2.NonIns 0.0017*** 0.0019*** 0.0016*** 0.0020***
(0.000) (0.000) (0.000) (0.000)
Industry variables Controlled Controlled controlled controlled
Number of Samples N 8300 19500 8300 19500

Note: The table employs the LIML regression approach. The symbols "*," "**," and "***" in the table indicate that the statistic is significant at the 10%, 5%, and 1% levels, respectively. The explanatory variable is the shareholding ratio of an insurance institution with a first lag, and the explained variable is the two-period lagged EPS of the company. With a unified second lag, the control variable is the same as the explained variable. For weak instrumental variables in the table, the CD statistic and the KP statistic are both more than 10, and there is no weak instrumental variable. Table 6 does not give other statistics since the setup of the counterfactual test model is inconsistent with the actual situation. It primarily tests the relationship between the holdings of insurance institutions and the company value in the past.

Robustness test

This paper replaces the EPS with two alternative proxies: ROA and ROE, respectively, in the value selection model (A) and value creation model (B). The model parameters were re-estimated individually to assess the importance of the coefficients of the key examined variables. Table 7 displays the model’s output. Long-term shareholding insurance institutions’ value selection and creation are reported in columns (1)—(4) of Table 7, while FIFO insurance institutions’ value selection and creation are reported in columns (5)—(8). It can be inferred from the table that the value selection model of the impact of long-term shareholding insurance institutions on listed companies, the coefficients of insurance shareholding ratio (0.0460, 0.0561), and the coefficients of insurance shareholding ratio (0.1575, 0.1767) in the sample of FIFO shareholding insurance institutions are positive at a significance level of more than 10%. This is consistent with the assumption that insurance institutions have the function of value selection in H1, and the results when EPS is the explained variable (Table 4). Among the results of the value creation model, the long-term shareholding value creation results are shown in columns (3) and (4). The coefficients of the insurance shareholding ratio (0.4833, 0.5683) are positive at the 10% significance level, which confirms hypothesis H3a. The FIFO shareholding value creation results are shown in columns (7) and (8). At the 5% significance level, the coefficients of the insurance shareholding ratio (-0.6118, -0.6232) are negative, which is consistent with the theoretical analysis of hypothesis H2. The results of the value creation model are also consistent with Table 5.

Table 7. Test of alternative proxies.

Variable Long-term holding Fast in and fast out
ROA ROE D. ROA D. ROE ROA ROE D. ROA D. ROE
Value selection model Value creation model Value selection model Value creation model
(1) (2) (3) (4) (5) (6) (7) (8)
L.Shareh 0.0460** 0.0561** 0.1575* 0.1767***
(0.021) (0.027) (0.083) (0.061)
D.Shareh 0.4833** 0.5683* -0.6118** -0.6232**
(0.243) (0.330) (0.269) (0.260)
L. ROA 0.6815*** 0.4336***
(0.071) (0.120)
L. ROE 0.2120***
(0.051)
L2. ROA -0.4575***
(0.147)
L2. ROE 0.6547*** -1.7999***
(0.152) (0.156)
Grow 0.2096***
(0.031)
AssLia -1.6257***
(0.462)
LogAss 0.0077*** 0.0148*** 0.0066*** 0.0093*** 0.0100*** 0.0157*** 0.0054*** 0.0109***
(0.000) (0.001) (0.000) (0.001) (0.000) (0.000) (0.001) (0.001)
Conc -0.0316** -0.0100 -0.0370 0.0790*** -0.0607*** -0.0206*** -0.1103*** -0.0760***
(0.015) (0.007) (0.023) (0.014) (0.015) (0.005) (0.031) (0.013)
NonIns -2.7673** 1.2689*** -3.0164* -2.1187*** -3.3992*** 1.4382*** 0.0770 4.2851***
(1.153) (0.396) (1.818) (0.706) (1.069) (0.265) (1.360) (0.738)
Industry variables Controlled Controlled Controlled Controlled Controlled Controlled Controlled Controlled
Number of Samples N 8715 8715 8715 8715 19500 19500 19500 19500

Note: The table employs the LIML regression approach. The symbols "*," "**," and "***" in the table indicate that the statistic is significant at the 10%, 5%, and 1% levels, respectively. The alternative proxies of EPS, namely ROA and ROE, are the explanatory variables of the value creation model, while the lag terms of the shareholding ratio of insurance institutions (Shareh) are the corresponding explanatory variables, and the instrumental variable is the information degree of institutional investors’ equity (Insfir3, Insfir5) and the lag terms of the corresponding explained variables; The difference terms D.ROA and D.ROE of ROA and ROE are the explained variables of the value creation model. The corresponding explanatory factors are the difference terms of the shareholding ratio of insurance institutions (D.Shareh). The instrumental variables are institutional investors’ equity information degrees (Insfir3, Insfir5) and the explained variables’ second-order lag terms.

Further research

The sample type—categorization criteria, is further narrowed in this research to explore the performance of value selection and creation methods across longer and shorter holding periods. This classification is a more in-depth research challenge and a strong evaluation of the results of this work from a different perspective. The comparison also reflects the stability of the value creation and value selection functions. The average holding period of insurance institutions above 1.5 times is recorded as a sub-sample with a longer holding period (long-term holding type 2). Similarly, holding periods of less than 0.5 times are recorded as a subsample of FIFO holdings with more frequent investment conversions (FIFO type 2), and model parameters are estimated using the value-selection model (A) and value-selection model (B). Table 8 displays the model’s output. The FIFO type 2 IIIs have a more obvious value selection function than the FIFO type IIIs in Table 4, as shown in Table 8. The coefficient increased from 0.00509 (column (3) of Table 4) to 0.0170 (column (2) of Table 8), and the significance level increased from 10% to 5%, indicating that IIIs with shorter-term investment horizons face greater pressure to maintain the value of debt funds, and will actively utilize its advantages in information collection to seek high-quality companies to maximize the value of their debt funds.

Table 8. Value selection and creation models with longer duration for long-term holding and shorter duration for FIFO.

Value selection model (EPS) Value creation model (D.EPS)
Long-term holding 2 FIFO 2 Long-term holding 2 FIFO 2
(1) (2) (3) (4)
L.Shareh 0.0048** 0.0170**
(0.002) (0.007)
D.Shareh 0.0245* -0.0068**
(0.013) (0.003)
L.EPS 0.5220*** 0.5841***
(0.041) (0.045)
L2.EPS -0.2163*** -0.2322***
(0.021) (0.016)
Grow 0.0003*** 0.0002*** 0.0002*** 0.0002***
(0.000) (0.000) (0.000) (0.000)
AssLia 0.0003 -0.0006 0.0006 -0.0004
(0.000) (0.000) (0.000) (0.000)
LogAss -0.1070** 0.0013 -0.0936** -0.0238
(0.047) (0.025) (0.046) (0.017)
Conc 0.0016* 0.0001 -0.0002 -0.0002
(0.001) (0.000) (0.001) (0.000)
NonIns 0.0023*** 0.0023*** 0.0013*** 0.0012***
(0.001) (0.001) (0.000) (0.000)
Industry variables Controlled controlled controlled controlled
Joint significance 33.42*** 88.77*** 15.03*** 30.48***
Under-identification 170.042*** 158.810*** 51.411*** 210.127***
Weak instrumental variables (CD) 388.447 406.527 30.646 1294.807
Hensen J 0.598 3.844 0.394 4.062
Number of Samples N 5754 14700 5754 14700

Note: In the table, the LIML regression approach is utilized. The joint significance of the time dummy variables is referred to as joint significance. The symbols "*," "**," and "***" in the table indicate that the statistic is significant at the 10%, 5%, and 1% levels, respectively. "In the first-stage regression, the instrumental variables utilized have no explanatory power for endogenous variables," is the null hypothesis of the under-identification test, and the value of the under-identification test in this work considerably rejects the null hypothesis. In the weak instrumental variable test table, only the CD statistic is presented. It is difficult to reject the null hypothesis—"the instrumental variable is significantly associated with the endogenous variable," that is, there is no weak instrumental variable problem, if the CD value is more than 10. The results of the over-identification test were reported by Hansen J. The number of instrumental variables in this study is more than the number of endogenous variables, meeting the over-identification test’s prerequisite. The null hypothesis of "all instrumental factors are exogenous" is not rejected, and Hansen J’s findings are not significant. It demonstrates the consistency with which model instrumental variables were chosen

Long-term holding type 2 has a substantial value selection function with a slight improvement in the coefficient (0.0048 (column (1) of Table 8) > 0.00463 (column (1) of Table 4), indicating that insurers are more cautious for longer-term holdings. The value creation effect of long-term holding type 2 IIIs is stronger in the value creation model, with the coefficient increasing from 0.0168 (column (1) of Table 5) to 0.0245 (column (3) of Table 8). Despite the decrease in significance level, it illustrates that the more IIIs whose purpose is to hold shares for a long time, the more motivated they are to participate in corporate supervision and corporate governance, resulting in a value-creating influence on the company they own. The FIFO type 2 still lacks a value creation function and has a detrimental impact. Although there are slight differences between the results in Table 8 and Tables 4 or 5, the direction and significance of the coefficients are consistent with the assumptions and regression results of this research, which further verifies the robustness of the conclusions.

Conclusion and policy recommendation

While there is a multitude of research on the influence of institutional investor holdings on business value, there is little research that focuses on IIIs exclusively. Studies on IIIs have become increasingly essential and meaningful with the growing importance of the insurance industry in the financial sector, and the conflicts resulting from insurance funds owning shares in major Chinese real estate enterprises. This article examines the impact of IIIs on the companies they hold in a methodical and in-depth manner from the perspectives of value selection and creation. This study is separated into FIFO stock holdings and long-term stock holdings from the standpoint of value creation, and higher stock replacement frequency and longer stock holding periods. This article derives the following findings based on the quarterly data of listed businesses held by 1,654 insured institutions in China from 2012 to 2018: (1) Long-term equity-holding IIIs have both value selection and value creation functions; (2) the value creation function becomes more important among long-term stock-holding IIIs with an increase in the period during which they retain the company’s shares; (3) FIFO IIIs have a value-inhibiting effect on the held company and serve a value selection role, rather than a value creation function.

The following aspects highlight the contributions of this paper: Theoretically, this paper examines the value creation of insurance companies from the perspectives of positive and negative motivation. It also examines the characteristics of insurance funds, insurance business, insurance industry chain extension, new accounting standards, and the impact of different stages of insurance company development on the value creation of insurance institutions. The extant literature on institutional investors’ impact on company value is less focused on insurance companies. This work adds to the body of knowledge about institutional investors’ heterogeneity. Additionally, theoretical analysis offers organizations with judgement criteria for determining the motives of insurance institution investment shareholders to some extent. The findings of this article give an empirical basis for regulators to encourage long-term holdings by insurance firms, differentiate the value creation function from the standpoint of investment horizon, and dispute the notion that IIIs are "barbarians". The study’s findings give a reasonable foundation for businesses to deal with IIIs’ holdings correctly. The empirical findings suggest that a held corporation can be exposed to IIIs, particularly long-term IIIs. However, for FIFO IIIs, it is vital to protect the company’s value from unfavorable effects.

This study makes the following practical recommendations based on a theoretical and empirical analysis of the entire material. First, incentive mechanisms and policy measures should be implemented by regulatory authorities to encourage insurance companies to hold long-term shares. Long-term insurance company ownership of high-quality enterprises is a win-win situation with favorable externalities. Our findings show that long-term shareholding can meet the long-term liabilities characteristics of insurance funds, meet the extension of the insurance industry chain, adapt to new accounting standards to make investment performance more stable, avoid frequent selection of corporate shareholding, and reduce labor costs and risks for insurance companies. Additionally, it can increase the value of a company, according to the empirical analysis in this paper. Furthermore, encouraging insurance companies to hold long-term shares will result in beneficial capital market externalities. The lack of long-term consistent capital flows in the capital market contributes to the degree of stock market volatility. Long-term shareholding by insurance companies will help to smooth out the stock market’s severe volatility. However, appropriate regulatory policies are required to promote insurance’s role as a societal "stabilizer." Equity participation requirement for IIIs being lowered even more may lead to the encouragement of value investing, and long-term investing and participation in corporate governance. Furthermore, laws and regulations governing equity investment, as well as the information disclosure system, should be improved to reduce speculation among small shareholders and other investors, prevent shareholders and managers from colluding to artificially raise stock prices, and limit potential speculative behavior at the legal system level. It is more beneficial to increasing the company’s worth and allow it to develop in a sustainable manner.

Second, privately held companies must avoid perceiving insurance institutions as "savages". The company’s shareholding structure should be given top priority by businesses, and appropriate steps must be taken to ensure that the ownership structure of the company is not overly dispersed. The most fundamental and effective strategy to control the corporation is to maintain a relatively favorable shareholding. The company’s articles of association and system, board of directors and independent director system, and decision-making process must all be upgraded to avoid hostile takeovers by institutional investors. Finally, corporate management should work together with insurance institutional investors, approach different insurance institutional investors differently, assess whether they have positive value creation goals, and make decisions that benefit the company’s value. They should pay close attention to changes in shareholdings in the capital market and avoid excessive group speculation driven by short-term insurance institutional investors to protect the company’s long-term strategic worth. This article’s focus on the impact of Chinese insurance institutions’ shareholdings on firm value can be useful as a benchmark for other nations, particularly emerging economies.

The study has the following shortcomings, flaws, and future research directions. First, this paper examines the IIIs on their own, while considering the diversity of institutional investors. However, the impact of shareholding by different types of insurance companies on business value is not examined further. How does shareholding by life and property insurers effect the company’s value differently? What is the difference between small and medium insurers, and large insurance groups when it comes to the influence of equity holdings on company value? Do insurance companies at different stages of development have different effects on the value of the held company? The classification research of insurance businesses may provide regulatory agencies and companies with more information and assistance. Second, while this article indicates that long-term shareholding by insurance institutions can increase a company’s value, it does not go into detail on how this can be done. Does shareholding by IIIs increase the company’s value via strengthening internal governance, lowering agency costs, enhancing business synergy, or in other ways? These kind of path analyses can help insurers and stakeholders collaborate more effectively. Third, the types of companies in which insurance companies own shares are not distinguished in this article. Which sort of company’s value grows faster and which grows slower for insurance institutions’ long-term holdings? Should IIIs concentrate their efforts on holding companies that collaborate with the insurance industry? Is there a difference in the impact of an insurance company’s shareholding on a profitable or loss-making business? Such corporate heterogeneity research could serve as a guide and aid to insurance organizations to utilize their money better and select appropriate shareholding objectives. Fourth, it is also interesting and meaningful to observe the performance changes of value selection and value creation under different insurance institutions’ shareholding ratios by using quantile grouping. Our results hold up for only observations with positive EPS, ROA or ROE. Sometimes when companies are going through serious difficulties their normal “roles or priorities” change.

Furthermore, since our data comes from China, what are the variances in the impact of insurance institutional investors on corporate value in different countries? What are the causes of these discrepancies? The questions above are additional in-depth inquiries that we did not address in this article. These and other related concerns are research topics that need to be addressed in the future.

Supporting information

S1 Data

(ZIP)

Acknowledgments

We would like to acknowledge the valuable suggestions of the editor and anonymous reviewers. We also give sincere gratitude to Dr. Weiwei Cui (Southwestern University of Finance and Economics) and Shuangrui Han (Southwestern University of Finance and Economics) for their devoted work and data processing for this manuscript.

Data Availability

The data that support the findings of this study are openly available in the Wind Financial Database at (http://www.wind.com.cn), RESET Database at (https://db.resset.com) and CSMAR Database at (http://www.gtadata.com).

Funding Statement

T.Z., Grant No. 71902163, the National Natural Science Foundation for Young Scientists of China, http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. T.Z., Grant No. 2019040027 and the Humanities and Social Sciences Youth Foundation of Ministry of Education of China,http://www.moe.gov.cn/s78/A13/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Ge S. and Weisbach M.S. (2021). The role of financial conditions in portfolio choices: The case of insurers. Journal of Financial Economics, 142:803–830. [Google Scholar]
  • 2.Liu L., Wang X., and Zhang W. (2019). The study on the impact of insurance companies’ stock holdings on share price volatility of listed companies. Insurance Studies, 2:28–40. [Google Scholar]
  • 3.Black J.K., Skipper H.D. and Black K. III (2015). Life Insurance, 15th Ed. Hardcover. [Google Scholar]
  • 4.Huo X., Lin H., Meng Y. and Woods P. (2021). Institutional investors and cost of capital: the moderating effect of ownership structure. Plos One, 16:1–18. doi: 10.1371/journal.pone.0249963 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lou W. (2002). An empirical study on the correlation between fund holdings and listed company performance. Shanghai Journal of Economics, (06):58–62. [Google Scholar]
  • 6.McConnell J.J. and Servaes H. (1990), Additional evidence on equity ownership and corporate value. Journal of Financial Economics, 27(2):595–612. [Google Scholar]
  • 7.Shi M.J. and Tong W.H. (2009). Do institutional investors enhance company value?—Empirical evidence from the post-stock reform period. Journal of Financial Research, (10):150–161. [Google Scholar]
  • 8.Strickland J.W., Idler R.S., Lourie G.M. and Plancher K.D. (1996). The hypothenar fat pad flap for management of recalcitrant carpal tunnel syndrome. J Hand Surg Am, 21(5): 840–848. doi: 10.1016/S0363-5023(96)80201-2 [DOI] [PubMed] [Google Scholar]
  • 9.Shleifer A. and Vishny R.W. (1986). Large shareholders and corporate control. Journal of Political Economy, 94(3):461–488. [Google Scholar]
  • 10.Cheng S.Q. (2006). An empirical study on the relationship between institutional investors’ shareholding and accounting earnings information of listed companies. Management World, (04):1401–1418. [Google Scholar]
  • 11.Chung K.H. and Zhang H. (2011) Corporate governance and institutional ownership. Journal of Financial and Quantitative Analysis, 46(1):247–273. [Google Scholar]
  • 12.Mei J. and Zhang M.Z. (2016). Do funds lead the institutional investors to govern listed firms’ earnings management: analysis based on the endogenous view. Accounting Research, (04):55–60+96. [Google Scholar]
  • 13.Velury U. and Jenkins DS. (2006) Institutional ownership and the quality of earnings. Journal of Business Research, 59(9):1043–1051. [Google Scholar]
  • 14.Li Y.L., Sun J.F. and Yi Z.H. (2012). Corporate heterogeneity, perquisites and the roles of institutional investors in corporate governance. Journal of Finance and Economics, 38(06):27–37. [Google Scholar]
  • 15.Lu Y., Zhu Y.J. and Hu X.Y. (2012). Institutional shareholding and corporate fraud: evidence from china. Nankai Business Review, 15(01):13–23. [Google Scholar]
  • 16.Pan Y., Dai Y.Y. and Wei S.Q. (2011). Do institutional investors collude with listed companies: analysis based on non-voluntary management turnover and selection of succession. Nankai Business Review, 14(02):69–81. [Google Scholar]
  • 17.Zhang D.X. and Qu Y.Z. (2018). The impact of institutional ownership persistence on listed firms’ performance and risk. System Engineering Theory and Practice, 38(02):273–286. [Google Scholar]
  • 18.Coffee J. (1991). Liquidity versus control: the institutional investor as corporate monitor. Columbia Law Review, 91(6):1277–1368. [Google Scholar]
  • 19.Li W.A. and Li B. (2008). An empirical study on the effect of institutional investors participating in corporate governance: Based on the data of 2004–2006 CCGINK. Nankai Business Review, (01):4–14. [Google Scholar]
  • 20.Robert W., Matthias B. and Roddy M.K. (2003). Problems and limitations of institutional investor participation in corporate governance. Corporate Governance: An International Review, 11(1): 65–73. [Google Scholar]
  • 21.Wahal S. (1996). Public pension fund activism and firm performance. Journal of Financial and Quantitative Analysis, 31: 1–23. [Google Scholar]
  • 22.Pouraghajan A., Oskou V., Ashtiyani M. and Mohseni E. (2013). The survey of relationship between price stocks with selected components of cash flow statement in the companies listed in the tehran stock exchange. Journal of Basic and Applied Scientific Research. 3(5): 68–77. [Google Scholar]
  • 23.Chen X., Harford J. and Li K. (2007). Monitoring: which institutions matter? Journal of Financial Economics, 86(2):279–305. [Google Scholar]
  • 24.Fu C.R. (2017). Institutional investors and intellectual capitals: value selection or value creation? Humanities & Social Sciences Journal of Hainan University, 35(02):75–84. [Google Scholar]
  • 25.Li L. and Han L.Y (2014). Value investing or value creating? a comparative study between foreign and domestic institutional investors. China Economic Quarterly, 13(01): 351–372. [Google Scholar]
  • 26.Tang S.L., Lin S.Y. and Gao L.L. (2015). Institutional ownership, free cash and investment efficiency. Business Review, 27(01):24–35. [Google Scholar]
  • 27.Tang Y.J. and Song Y.Y. (2010). Value-selection vs. value-creation: evidence from institutional investors in the chinese market. China Economic Quarterly, 9(2): 609–632. [Google Scholar]
  • 28.Li H., Li S., Zhan X., Zhang F., and Sun M. (2022). Corporate social responsibility and cross-border M&A: The moderating effect of institutional distance. PLoS ONE, 17(1): e0262343. doi: 10.1371/journal.pone.0262343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Aggarwal R., Erel I., Ferreira M. and Matos P. (2011). Does governance travel around the world? Evidence from institutional investors. Journal of Financial Economics, 100 (01): 154–181. [Google Scholar]
  • 30.Mu L.J. and Zhang H. (2008). Study on relationship between shares-propotion of institutional investors and corporation performance of listed companies—Based on empirical data of Chinese listed companies. Journal of Beijing Technology and Business University (Social Science Edition), (04):76–82. [Google Scholar]
  • 31.Shi L.P. and Li Y. (2007). Research on the role of institutional investors involved in corporate governance. Shanghai Journal of Economics, (07):83–90. [Google Scholar]
  • 32.Wu X.H. and Jiang Y.F. (2006). Research on governance efficiency of institutional investors. Statistical Research, (09):33–36. [Google Scholar]
  • 33.Wang Y.Y. and Ge H.Y. (2017). A research on the shareholding preference of insurers and the influence on performance of listed companies—Evidence from a share market in china. Insurance Studies, 8: 89–104. [Google Scholar]
  • 34.Wen J. and Feng G.F. (2012). Heterogeneous institutional investor, nature of firm and independent innovation. Economic Research Journal, 47(03): 53–64. [Google Scholar]
  • 35.Bushee B.J. (1998). The influence of institutional investors on myopic R&D investment behavior. Accounting Review: 305–333. [Google Scholar]
  • 36.Parrino R., Sias R.W. and Starks L.T. (2003). Voting with their feet: institutional ownership changes around forced CEO turnover. Journal of financial economics, 68(1): 3–46. [Google Scholar]
  • 37.Bushee B.J. (2001). Do institutional investors prefer near-term earnings over long-run value? Contemporary Accounting Research, 18(2): 207–246. [Google Scholar]
  • 38.Lin L.N. (2017). Problems and countermeasures of financial management of financing guarantee companies. Global Market Information Guide, 49:26. [Google Scholar]
  • 39.Xin H. Z. (2017). Institutional investors’ heterogeneity, continued duration of stock ownership and firm performance. Journal of Shanxi University of Finance and Economics, 39(04): 112–124. [Google Scholar]
  • 40.Yao Y., Liu Z. Y. (2009). Do institutional investors have a supervisory role? Financial Research, (06):128–143. [Google Scholar]
  • 41.Cheng J., Elyasiani E. and Jia J. (2011). Institutional ownership stability and risk taking: Evidence from the life–health insurance industry. Journal of Risk and Insurance, 78(3): 609–641. [Google Scholar]
  • 42.Derrien F., Kecskés A. and Thesmar D. (2013). Investor horizons and corporate policies. Journal of Financial and Quantitative Analysis, 48(6): 1755–1780. [Google Scholar]
  • 43.Borokhovich K.A., Brunarski K., Harman Y.S. and Parrino R. (2006). Variation in the monitoring incentives of outside stockholders. The Journal of Law and Economics, 49(2): 651–680. [Google Scholar]
  • 44.Brickley J.A., Lease R.C. and Smith C. Jr. (1988). Ownership structure and voting on antitakeover amendments. Journal of Financial Economics, 20: 267–291. [Google Scholar]
  • 45.Almazan A., Hartzell J.C. and Starks L.T. (2005). Active institutional shareholders and costs of monitoring: Evidence from executive compensation. Financial management, 34(4): 5–34. [Google Scholar]
  • 46.Hartzell J.C. and Starks L.T. (2003). Institutional investors and executive compensation. The Journal of Finance, 58(6): 2351–2374. [Google Scholar]
  • 47.Bamahros H.M. and Wan-Hussin W.N. (2015). Types of institutional investors and earnings management in Malaysia. Advanced Science Letters, 21(6): 2003–2006. [Google Scholar]
  • 48.Deng D.Q., Wen S.B., Pan L.N. and Liu H.T. (2014). Internal control quality, heterogeneity of institutional investors and decision-making: Base on the self-selection model. Management Review, 26(10):76–89. [Google Scholar]
  • 49.Zhao H.J. and Xia H. (2009). An empirical study on relationship between the stock holding of institutional investor and companies innovation activity. China Soft Science, (05):33–39+54. [Google Scholar]
  • 50.Liang S.K. (2018). Will institutional investor holdings affect the cost stickiness of companies? Management World, 34: 133–148. [Google Scholar]
  • 51.Cornett M.M., Marcus A.J., Saunders A and Tehranian H. (2007). The impact of institutional ownership on corporate operating performance. Journal of Banking & Finance, 31(6):1771–1794. [Google Scholar]
  • 52.Ferreira M., and Matos P. (2008). The colors of investors`money: the role of institutional investors around the world. Journal of Financial Economics, 88: 499–533. [Google Scholar]
  • 53.Healy P.K. (1992). Does corporate performance improve after mergers?. Journal of Financial Economics, (31): 135–175. [Google Scholar]
  • 54.Huang L., Wang H.C. and Qiu Y.Z. (2009). Does tobin’s Q provide a useful measure of firm value? The Perspective of Capital Market Speculation, 12(01):90–95+123. [Google Scholar]
  • 55.Chaganti R. and Damanpour F. (1991). Institutional ownership, capital structure, and firm performance. Strategic Management Journal, 12(7):479–491. [Google Scholar]
  • 56.Kang D. L. (2000). The impact of activist institutional investors on performance in public corporations: A study of the u.s. fortune 500, 1982–1994. Academy of Management Annual Meeting Proceedings, (1), H1-H6. [Google Scholar]
  • 57.Sundaramurthy C., Rhoades D. and Rechner P.L. (2005). A meta-analysis of the effects of executive and institutional ownership on firm performance. Journal of Managerial Issues,17(4): 494–510. [Google Scholar]
  • 58.Demsetz H. (1983). The structure of ownership and the theory of the firm. The Journal of law and economics, 26(2): 375–390. [Google Scholar]
  • 59.Demsetz H. and Lehn K. (1985). The structure of corporate ownership: Causes and consequences. Journal of political economy, 93(6): 1155–1177. [Google Scholar]
  • 60.Arellano M., Bond S. (1991). Some tests of specification for panel data: Monte carlo evidence and an application to employment equations. The Review of Economic Studies, 58(2): 277–297. [Google Scholar]
  • 61.Berle A. and Means G. (1991). The modern corporation and private property. New Brunschwick: 66. [Google Scholar]
  • 62.Chen X.Y. and Xu X.D. (2001). Equity structure firm performance and the protection for investers’ interest. Economic Research Journal, (11):3–11+94. [Google Scholar]
  • 63.Jensen M. and Meckling W. (1976). Theory of the firm: managerial behavior, agency costs and ownership structure. Journal of Financial Economics, 3:305–360. [Google Scholar]
  • 64.Morck R., Shleifer A. and Vishny R.W. (1988). Management ownership and market valuation: An empirical analysis. Journal of Financial Economics, 20: 293–315. [Google Scholar]
  • 65.Hansen C., Hausman J. and Newey W. (2008). Estimation with many instrumental variables. Journal of Business & Economic Statistics, 26(4): 398–422. [Google Scholar]
  • 66.Elyasiani E. and Jia J.J. (2008). Institutional ownership stability and BHC performance. Journal of Banking & Finance, 32(9): 1767–1781. [Google Scholar]
  • 67.Fan J.P.H., Titman S. and Twite G. (2012). An international comparison of capital structure and debt maturity choices. Journal of Financial and quantitative Analysis, 47(1): 23–56. [Google Scholar]
  • 68.He Y.L., Zhang Y.W. and Mo J.M. (2014). The influence of ownership concentration on the corporate performance under different regional governance environment. Journal of Financial Research, (12): 148–163. [Google Scholar]
  • 69.Zhen H.X., Zhang X.Z. and Chi G.T. (2015). The effect of the institutional environment and ultimate control on corporate performance: Based on the test of mediator effect of agency costs. Journal of Financial Research, (12):162–177. [Google Scholar]
  • 70.Dharwadkar R., Goranova M., Brandes P. and Khan R. (2008). Institutional ownership and monitoring effectiveness: it’s not just how much but what else you own. Organization Science, 19(3): 419–440. [Google Scholar]
  • 71.Tang Y.J. and Li W.A. (2008). Corporate harmony, stakeholders governance and corporate performance. China Industrial Economics, (06):86–98. [Google Scholar]
  • 72.Song M., Zhang J.X. and Li C.T. (2004). A trap in the ownership structure for listed companies. Nankai Business Review, (01):9–23+56. [Google Scholar]
  • 73.Li S.M., Zhou M.T. and Yu P.Y. (2006). Study of property of ultimate ownership and governance mechanism’s impact on corporate performance. Journal of Management Science, (05):9–16. [Google Scholar]
  • 74.Levin A., Lin C. and Chu C.J. (2002). Unit root tests in panel data: Asymptotic and finite-sample properties. Journal of Econometrics, 108: 1–24. [Google Scholar]
  • 75.Massa M., Yasuda A. and Zhang L. (2013). Supply uncertainty of the bond investor base and the leverage of the firm. Journal of Financial Economics, 110(1): 185–214. [Google Scholar]
  • 76.Stock J.H. and Yogo M. (2005). Testing for weak instruments in linear IV regression. Nber Technical Working Papers, 14(1): 80–108. [Google Scholar]
  • 77.Scott F.J., Simon B.C. and Leslie A. (1999). ’If pigs could fly’: A test of counterfactual reasoning and pretence in children with autism. British Journal of Developmental Psychology, 17(3). [Google Scholar]
  • 78.Fernandez S.P. (2014). Three essays in counterfactual econometrics.[D]. University of California, Berkeley. [Google Scholar]

Decision Letter 0

J E Trinidad Segovia

10 Jan 2022

PONE-D-21-31055The impact of insurance institutional investors on corporation value from selection and creation perspectivePLOS ONE

Dear Dr. Liu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, I feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, I invite you to submit a revised version of the manuscript that addresses the points raised during the review process. I agree with the reviewers that there are many major concerns that need to be addressed before considering the paper for publication. The introduction section does not provide enough information to justify the research of this paper. The contribution and the findings must be clarified.

On the other hand, the importance of this topic as well as the limitation to China must be also clarified. Probably it should be interesting to attend the reviewers one suggestion about this point.

I find also that the literature review section is not properly organized, so it is difficult to follow and to understand.

Other major concerns are referred to the methodological section of the manuscript. There is not a clear justification for why this methodology is used or the variables were selected.

Finally, I agree with the reviewers that the conclusion section needs to be improved. The results must be compared with other previous findings of the literature on this topic.

Please submit your revised manuscript by Feb 24 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

J E. Trinidad Segovia

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you very much for giving me the opportunity to review the article ‘The impact of insurance institutional investors on corporation value from selection and creation perspective’. This study seeks to examine the influence of insurance institutional investors on company value selection and creation. While interesting, I have several important concerns, which I explain following the structure of the manuscript:

1. Abstract

I suggest author(s) make an extra effort to write a more attractive abstract. It would be interesting to at least state the main objective of the study and highlight the most important findings. For example, you state that ‘The impact that insurance institutional investors have on corporations is an urgent problem addressed in academic and practical research’, but why it is an urgent problem? In my opinion, this is not clear in the summary, nor in the full article.

2. Introduction

The introduction is extremely poor. It is not clearly explained why this study is necessary. The goals pursued are also unclear. Until the ‘Research Hypothesis’ section, it did not seem very clear to me what specific goals the author(s) are addressing in this article. I encourage author(s) to explicitly state the research goals/questions and develop the motivation for why it is necessary to carry them out. To this end, I suggest the following:

1. Rewrite the introduction following the traditional structure of 2 pages and 4 paragraphs: (1) review of what we know about the research topic; (2) identification of research gaps that your research fills; (3) research objectives and brief description of how author intends to achieve those objectives; and (4) contributions to the literature.

2. Include calls from scholars for research on this topic and explain why these scholars have called for research on this topic.

The paper focuses on China, but why China? Justifying the context in which your study takes place, as well as explaining why this context is appropriate for analysing your research question, can improve the quality of the manuscript and help readers better understand the results.

Why is it important to analyse the impact of institutional insurance investors on value selection and creation and no other types of investors? What differentiates them from other investors with respect to these issues? Are there any particularities that make their study interesting in terms of value selection and creation?

As the introduction should be reviewed to strengthen motivation, similar changes should be considered in the conclusion to provide a more accurate picture of how your study makes a value-added contribution to the literature and how your study offers some practical implications.

3. Literature review, Theoretical Analysis and Hypothesis

This section is to some extent confusing. I see a lack of common thread, as each subsection does not link with the rest, and the hypotheses are very poorly justified. I suggest the following structure:

1. A first subsection dedicated to insurance institutional investors, their conceptualisation, their main and most important differences with respect to other investors, their singular impact on company value selection and creation, etc. In my opinion, the inclusion of this subsection would be extremely important, as insurance institutional investors, as a concept, is not properly defined throughout the paper.

2. A second subsection which reviews prior literature directly related to the topic, and explains how such studies give rise to the present work.

3. A third subsection focusing on the effect of insurance institutional investors on company value selection and creation. This section should be devoted to providing more convincing and substantial arguments to justify how insurance institutional investors can affect company value selection and creation.

Finally, the research goals should be placed in the introduction section rather than in the Theoretical Analysis and Hypothesis section. As mentioned, this part should focus on providing stronger theoretical arguments to support the hypotheses under study.

4. Methodology

I encourage the author(s) to explain better why they have chosen the regression techniques used and not others. For example, why not SEM?

5. Empirical results

The authors should make a greater effort to find previous papers that confirms their results.

6. Conclusions

In this section, I really missed a deep reflection on the part of the author(s). As researchers, our work should reflect our ability to think and not just describe results. This paper reveals interesting results, and the importance of these results is not adequately reflected in this section. It would be interesting, for example, to relate the obtained results more closely to previous literature and to point out more explicitly the contributions of the study in comparison to the previous literature. In addition, it is very important to elaborate further on the contributions and practical implications, as well as to indicate some limitations and future avenues of research may help to guide future researchers in this field and improve the quality of the manuscript. For example, this section could also be strengthened by further detailing the practical implications of the study, e.g. for Chinese companies.

Other minor issues

-There are no references to PLOS ONE. Thus, I suggest authors to include some article from PLOS ONE to underline the importance of the topic for the journal.

In summary, this paper has some potential, but requires considerable improvement before it can be published. I hope that these comments will be helpful in improving the manuscript. Best wishes for the future!

Reviewer #2: I appreciate the opportunity to renew your manuscript entitled “The impact of insurance institutional investors on corporation value from selection and creation perspective”. The purpose of the paper is the impact that insurance institutional investors may have on corporations. I believe that you are exploring a interesting topic. From my point of view, your paper is promising although needs mayor improvements I hope you find them helpful.

Main Comments

The whole paper needs a English grammar review.

1. INTRODUCTION

I miss in this section the following aspects: gap in the literature that your paper aims to fill in, your contribution and findings. In this way, I think it is necessary to distinguish between this topic worldwide and specifically in China.

I suggest restructuring Sections “Introduction”, “Literature Review” and “Theoretical Analysis and Hypothesis”.

From lines 50 to 54 I think you need to add citations to support those statements.

The justification of you paper, lines 60-61 is quite weak.

2. LITERATURE REVIEW / THEORETICAL ANALYSIS / HYPOTHESES

As stated before, I believe you should restructure this section, linking the review of the literature to the hypothesis. Indeed, the hypotheses should be right after the literature review of each of them, as usual. There are a lot of information, but it is disconnected and its reading is quite messy, and sometimes, apparently, contradictory.

You show the arguments in the literature in favour and against the impact of insurance institutional investors on companies’ return. However, you do not take a position in your paper. Moreover, your review looks a kind of disconnected from the hypotheses. That is why I suggest restructuring the three first sections.

In line 73 you mention “information disclosure”, however I cannot see the link of this concept with your paper.

In line 131 is the first time you use the acronym CSR, and it is necessary to explain what these words stand for.

Citation in line 143 is wrong.

In lines 193-194 you state that you contribute to the literature analysing positive and negative motives, but I miss them in your paper.

In lines 216-217 you need to use citations to support such a strong assumption.

Lines 222-223 and 262 seem to be contradictory, as line 254 and 257-258.

In line 276, in your H1, suddenly, you use the term FIFO. You need to explain this concept and how it is connected to the literature and the aim of you paper before stating the hypothesis.

3. MODEL DESIGN AND VARIABLES

I strongly encourage you to re-write “Main Model Design” in a clearer way. It is difficult to understand your models.

In line 294, what is “issue t“? It means time, but you use different words.

In line 296, “control variables” instead of “control variable”.

Why are you using “L”, “L2” and “D”? Explain the economic reasoning and connect it to the hypotheses.

It is necessary to support with citations the different dependent variables shown in this section.

Regarding the endogeneity problem, in my case, it is the first time that I meet models like yours to deal with this potential problem. I believe either you strongly support your models (from A to D) with the literature or use the well accepted (system) GMM approach, which uses most of all the available moments (lags) for the independent and control variables. In your case, you only use the second lag (L2).

I believe that it could be useful to add in Table 2 and 3, variables used in your paper such as: InsFir3, InsFir5, InsDura.

4. DATA PROCESSING AND DESCRIPTIVE STATISTICS

A better explanation of the three requirements you mentioned in line 388.

Your sample started from 2012 to 2018 (25 quarters) but in line 411 you use data from 2010 to 2018 (33, segments). A better explanation is needed.

It is important to specify whether you are using a balanced or unbalanced panel. I think, reading your data in the regression tables that it is balanced, but you need you said clearer. But, if so, if it is balanced, you need to take care of the so-called “survival bias” effect in panel data set.

In line 407, you use the terms “ST” and “*ST”, again two new concepts suddenly shown in the paper. What do they stand for?

From line 418 to 416, what is it the “conversion” between x-times (e.g. 1.4 times) and quarters? Besides, why you select the criterium of “more than 11 quarters and less than 4”? Please, explain and support with the literature.

You must improve your description of the control variables. You does not describe all of them. What is “agency variable”? (again, suddenly, you use a new concept).

In Table 2, have you checked whether companies with many negative values in the dependent variables behave differently than companies with positive? Could it be possible to show a different behaviour? How have you treated outliers?

5. MODEL REGRESSION ANALYSIS AND CONTERFACTUAL TEST

Table 4 and 5 do not show the same format.

At the bottom of the regression tables, I suggest using the name of the tests applied (Hansen, Sargan), it could help.

In Table 6, are you using LIML or 2SLS?

Is there a connection between Table 6 and the hypotheses?

6. FURTHER STUDY

Why is the support (citations) used in the new “classification criteria” shown in this section?

In line 549, I might be wrong, but I think that the significance level does not improve as you stated. In line 557 I believe that “0.00463” is wrong, and the right number is “0.017”. In any case, explain better which tables you are comparing to avoid any misunderstanding.

In lines 563-564, what does it add this new “perspective”? Why?

Again, in Table 7, (Why 7.1?), are you using LIML or 2SLS?

7. CONCLUSION AND POLICY RECOMMENDATION

I miss in this section “limitations” and “implications” of your findings

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Jul 1;17(7):e0269520. doi: 10.1371/journal.pone.0269520.r002

Author response to Decision Letter 0


25 Mar 2022

Reviewer 1: We have incorporated all of your suggestions into our revision. Your constructive comments on the paper were extremely valuable in improving the quality of the paper. Thank you very much.

Reviewer 2: We have incorporated all of your suggestions into our revision. Your constructive comments on the paper were extremely valuable in improving the quality of the paper. Thank you very much.

Attachment

Submitted filename: Responses to Reviewer 2022_03_23 (final).docx

Decision Letter 1

J E Trinidad Segovia

22 Apr 2022

PONE-D-21-31055R1The Impact of Insurance Institutional Investors on Corporate Value from Selection and Creation PerspectivePLOS ONE

Dear Dr. Liu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, I feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, I invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

You will see from the referees’ comments that additional information needs to be provided, in regard to methodology and model design and variables, and I ask that this be provided before we consider your manuscript further.

Please submit your revised manuscript by Jun 06 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

J E. Trinidad Segovia

Section Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Author(s),

Thank you very much for the opportunity to review the R1 version of your manuscript. I would like to acknowledge your efforts to address my concerns with the previous version, as well as the other reviewer's comments and suggestions. I appreciate many positive aspects in the development of the manuscript. Below, I propose some suggestions that should be considered before publication:

- The paper would benefit (in my view) if you put the Sample Description section first, and then all the content related to Model Design and Variables.

- References should be ordered throughout the article according to PLOS ONE guidelines. That is, the first reference in the paper should be number 1, the next number 2, and so on.

Good luck with your research!

Reviewer #2: I really appreciate that my comments have helped to improve your paper, and I am glad that you have taken them into consideration. And I appreciate all the effort you have done.

Again, just to keep improving a little bit more the paper, new comments can be found below.

1. ABSTRACT

I recommend not to be so categorical when you state that “this study rectifies”. I could be much better to use a softer or smoother expression, such as “shed light”, “provides more insight…”.

2. INTRODUCTION

Although in the Abstract you explain what a IIIs is, I think that it is necessary to explain it again in this section.

When you start describing the three roles (line 53) of institutional investors, I think that you need to help readers to distinguish these three roles in the following paragraphs. You me it took time to distinguish them.

In lines 136-138 you repeat the “Vanke-Baoneng Battle” issue as you did in lines 45-47 using almost the same expression.

3. LITERATURE REVIEW / THEORETICAL ANALYSIS / HYPOTHESES

From my point of view a brief definition of the two types of investment roles would be welcome: value selection and value creation.

Regarding the three hypotheses, and to make you think for future papers, it would be interesting to analyse whether these hypotheses varies as the percentage of shares (Shareh variable) also varies, using for example, quartiles.

What is the added value of H2 compared to the empirical evidence of references 10, 44, 72 and 73? If this papers confirm that short-term IIIs’ stock investments cannon improve company performance, what are you added to the literature? Explain a little bit.

4. MODEL DESIGN AND VARIABLES

Citations from the literature justifying or supporting the “Model design for counterfactual testing” would be also welcome.

In your answers you mention that your paper follow Arellano and Bond (1991) but I cannot see the citation in the paper.

Regarding GMM, I really appreciate the effort you have done calculating and showing the outcome from GMM. In my opinion, GMM can be used unless there is a justification that the control variable cannot have potential problems of endogeneity. But you can keep the GMM outcome out of the paper, and available under request since the results almost are the same.

5. DATA PROCESSING AND DESCRIPTIVE STATISTICS

Again, to improve the paper or for a new one, I think that you could test whether your results hold up or change for only observations with positive EPS, ROA or ROE. Sometimes when companies are going through serious difficulties their normal “roles or priorities” change.

In Table 3, coefficient between Grown and Conc, there are five digits after dot (0.00300).

6. MODEL REGRESSION ANALYSIS AND CONTERFACTUAL TEST

In Table 5 you forgot to add the “Note” statements.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Jul 1;17(7):e0269520. doi: 10.1371/journal.pone.0269520.r004

Author response to Decision Letter 1


17 May 2022

Reviewer 1: We have incorporated all of your suggestions into our revision. They were very helpful. Thank you very much for your time.

Reviewer 2: We have incorporated all of your suggestions into our revision. They were very helpful. Thank you very much for your time.

Attachment

Submitted filename: Responses to Reviewer 2022_05_15.docx

Decision Letter 2

J E Trinidad Segovia

24 May 2022

The Impact of Insurance Institutional Investors on Corporate Value from Selection and Creation Perspective

PONE-D-21-31055R2

Dear Dr. Liu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

J E. Trinidad Segovia

Section Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

J E Trinidad Segovia

14 Jun 2022

PONE-D-21-31055R2

The Impact of Insurance Institutional Investors on Corporate Value from Selection and Creation Perspective

Dear Dr. Liu:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. J E. Trinidad Segovia

Section Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data

    (ZIP)

    Attachment

    Submitted filename: Responses to Reviewer 2022_03_23 (final).docx

    Attachment

    Submitted filename: Responses to Reviewer 2022_05_15.docx

    Data Availability Statement

    The data that support the findings of this study are openly available in the Wind Financial Database at (http://www.wind.com.cn), RESET Database at (https://db.resset.com) and CSMAR Database at (http://www.gtadata.com).


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES